(TargetLiberty.org) – Yet again, the Democratic Party’s internal splits are getting in the way of lawmaking. The party is trying to continue former President Donald Trump’s efforts to lower prescription drug prices – but they can’t agree on how to do it.
House Speaker Nancy Pelosi (D-CA) has come up with HR3, a plan to cut the price of medicine. The problem is that Pelosi has gone too far. She wants federal regulators to be able to set price caps on drugs – and, while it’s no surprise Republicans are opposed to that sort of government overreach, many Democrats are too.
A strong majority of voters support @HouseGOP’s bipartisan HR19 over @SpeakerPelosi's partisan HR3 for addressing prescription drug costs & opposition to HR3 increases dramatically when voters learn of the consequences of its policy provisions. Learn more: https://t.co/oibtl823na pic.twitter.com/ZGXR4zrFXA
— CFIF.org (@CFIFonline) June 8, 2021
With the Senate split 50-50, some Democrats in the upper chamber think Pelosi’s bill will die on the Senate floor if it gets that far. Assuming a party-line vote, the bill is dead if even one Dem votes against it, and at least four are not likely to support Pelosi. Instead, Senator Ron Wyden (D-OR) and a group of other Democrat moderates are drawing up a new bill in hopes of a bipartisan solution that would strip out the attacks on business and stick to the core aim – giving Americans access to cheaper medication.
Copyright 2021, TargetLiberty.org